LexDanaLexDanabeta
Inventor

Robert W. Kavash

Inventor
Glenside, PA, US

Overview

25→
Patents
2000–2019
Patent span
Human necessities
Primary field (CPC A)

Patents· 25 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations33%
C07DHeterocyclic compounds30%
A61KPreparations for medical, dental or toiletry purposes18%
C07CAcyclic or carbocyclic compounds13%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry3%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests3%
PatentTitleYear
10,213,415Compounds as opioid receptor modulators20199,700,542'Compounds as opioid receptor modulators'20179,205,076'Compounds as opioid receptor modulators'20158,946,475'Processes for preparing a polymeric compound'20158,772,325'Compounds as opioid receptor modulators'20148,609,709'Compounds as opioid receptor modulators'20138,530,655'HIV replication inhibiting pyrimidines'20138,354,556'Processes for preparing a polymeric compound'20138,344,011'Compounds as opioid receptor modulators'20138,003,789'HIV replication inhibiting pyrimidines'20117,786,158'Compounds as opioid receptor modulators'20107,763,631'Prodrugs of HIV replication inhibiting pyrimidines'20107,741,356'Compounds as opioid receptor modulators'20107,659,402'Piperidines as opioid receptor modulators'20107,276,510'HIV replication inhibitors'20077,202,381'Compounds as opioid receptor modulators'20077,041,681'Compounds as opioid receptor modulators'20067,037,917'HIV replication inhibiting pyrimidines'20067,034,019'Prodrugs of HIV replication inhibiting pyrimidines'20067,015,221'2,4-disubstituted triazine derivatives'20066,878,717'HIV replication inhibiting pyrimidines'20056,774,235'Trisubstituted 1,3,5-triazine derivatives'20046,638,932'2,4-disubstituted triazine derivatives'20036,372,729'Trisubstituted 1,3,5,-triazine derivatives'20026,150,360'Trisubstituted 1,3,5-Triazine Derivatives'2000

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2000–2019Patents assigned to JANSSEN PHARMACEUTICA NV (21)· patent assignee history
2000–2019Based in Glenside, PA, US· patent location history
2005–2006Based in Maple Glen, PA, US· patent location history
2013–2015Patents assigned to JANNSEN PHARMACEUTICA N V (3)· patent assignee history
2013Patents assigned to KAVASH ROBERT W (3)· patent assignee history
2013Patents assigned to AKEN KOEN JEANNE ALFONS VAN (1)· patent assignee history
2013Patents assigned to ANDRIES KOENRAAD JOZEF LODEWIJK MARCEL (1)· patent assignee history
2013–2015Based in Radnor, PA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
JANSSEN PHARMACEUTICA NV212000–2019
JANNSEN PHARMACEUTICA N V32013–2015
KAVASH ROBERT Wself32013
AKEN KOEN JEANNE ALFONS VAN12013
ANDRIES KOENRAAD JOZEF LODEWIJK MARCEL12013
Locations
LocationPatentsSpan
Glenside, Pennsylvania, US212000–2019
Radnor, Pennsylvania, US22013–2015
Maple Glen, Pennsylvania, US22005–2006